Overview
- 19 inspections across 19 sites are on record.
- 30 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-09-19.
At a glance
Inspections
19
Sites
19
Observations
30
Career since
Oct 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Nanhai Beisha Pharmaceutical Co., Ltd. | 19 Sep 2025 | Human Drugs | On file |
| Ningxia Qiyuan Pharmaceutical Co., Ltd. | 12 Sep 2025 | Human Drugs | On file |
| Livzon Group (Ningxia) Pharmaceutical Co., Ltd. | 5 Sep 2025 | Human Drugs | |
| Pharmaron Manufacturing Services (US) LLC | 17 Jul 2025 | Human Drugs | |
| Boothwyn Pharmacy LLC | 9 Jun 2025 | Human Drugs | On file |
Sites inspected
Nanhai Beisha Pharmaceutical Co., Ltd.Nanhai, Foshan, China1 insp.
Ningxia Qiyuan Pharmaceutical Co., Ltd.Yinchuan, China1 insp.
Livzon Group (Ningxia) Pharmaceutical Co., Ltd.Shizuishan, China1 insp.
Pharmaron Manufacturing Services (US) LLCCoventry, United States1 insp.
Boothwyn Pharmacy LLCKennett Square, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Victoria Spivak3 shared
Ruben C Quintana3 shared
Christina K Theodorou3 shared
Elena N Thomas2 shared
Paige R Mccoy2 shared
Adena S Yau2 shared
Karen A Briggs2 shared
Anastasia M Shields2 shared
Stephenie M Ortiz1 shared
Yaharn Su1 shared
Full investigator report
Get the verbatim findings behind Evan Tong's 30 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site